Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2021-02-15 Earnings Release
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Interim Results
Earnings Release Classification · 100% confidence The document explicitly states it announces the 'interim results for the six months ended 30 November 2020'. It contains detailed financial highlights (Revenue, Gross profit, Loss after tax) and operational updates typical of a periodic financial report covering less than a full year. The presence of 'Interim Results' and specific half-year financial figures strongly indicates this is a comprehensive report for an interim period, matching the definition of an Interim / Quarterly Report (IR). Although it mentions a presentation/conference call, the core content is the results themselves, not just the announcement of the results (RPA). H1 2021
2021-02-15 English
Notice of Half Year Results
Report Publication Announcement Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 6751M) dated January 25, 2021. The title is "Notice of Half Year Results." It explicitly states that the company "will be announcing its half year results for the six months ended 30 November 2020 on Monday, 15 February 2021." This document is not the actual half-year report (which would be an Interim Report, IR), but rather an announcement about *when* the results will be released, including details about analyst presentations and investor calls. According to Rule 2, when a document announces the publication of a report, it should be classified as a Report Publication Announcement (RPA).
2021-01-25 English
Directorate Change
Board/Management Information Classification · 100% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The core content announces that Dr Cheung To has stepped down as a non-executive Director of Oncimmune Holdings plc. This specific event—a change in the board of directors or senior management—directly corresponds to the definition of Board/Management Information (MANG). Although it is an RNS filing, the content is highly specific to a management change, making MANG the most accurate classification over the general RNS fallback.
2021-01-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the RNS Number '0318M' and the title 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, specifically when a shareholder crosses a notification threshold. Section 7 and 8 detail the resulting percentage of voting rights (9.84%) and the total number of voting rights. This directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ.
2021-01-18 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document is an official notification released via RNS (RNS Number: 6923L) dated January 14, 2021. The content explicitly details 'PDMR Dealing' (Persons Discharging Managerial Responsibilities Dealing) involving the disposal of ordinary shares by a Person Closely Associated (PCA) with a Non-Executive Director. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing'. The structure and content match the requirements for insider transaction reporting, which falls under the 'DIRS' code.
2021-01-14 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement identified by the 'RNS Number : 7656K' and the explicit mention of 'RNS, the news service of the London Stock Exchange'. The content specifically discloses the 'Total Voting Rights' as of a specific date (31 December 2020) in accordance with the 'Disclosure Guidance and Transparency Rules (DTR 5.6)'. This type of disclosure, which relates to the total number of shares and voting rights, does not fit neatly into the specific categories like 10-K, ER, or DIV. Since it is a standard regulatory disclosure provided via the RNS system and doesn't fit a more specific category (like DIRS or MRQ, which deal with specific transactions or ownership changes), the most appropriate classification is the general regulatory filing fallback category, RNS.
2021-01-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.